PolyPid PYPD
NASDAQ PYPD
$6.60 +0.29 (+4.60%)
At close: Nov 11, 2026 · 4:00 PM EST

PolyPid (PYPD) Other Accumulated Expenses (2019 - 2025)

Updated

PolyPid (PYPD) recorded Other Accumulated Expenses of $8,000 in Q4 2025, down 65.2% from $23,000 a year earlier.

Analysis

PolyPid (PYPD) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

Starting with Q4 2019, PolyPid's Other Accumulated Expenses history includes 11 quarters.

  • Annual Other Accumulated Expenses has a five-year compound annual growth rate of -66.5% (FY2020 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $23,000 in FY2024 (+27.8%), $18,000 in FY2023 and $3.67 million in FY2021 (+92.9%).
  • The Q4 2025 figure is the lowest quarterly Other Accumulated Expenses in data going back to Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PolyPid 114.87 Mn 83.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8,000.00
Dec 31, 2024 23,000.00
Dec 31, 2023 18,000.00
Dec 31, 2021 3.67 Mn
Sep 30, 2021 3.49 Mn
Jun 30, 2021 2.57 Mn
Mar 31, 2021 2.04 Mn
Dec 31, 2020 1.90 Mn
Sep 30, 2020 1.11 Mn
Jun 30, 2020 3.31 Mn
Dec 31, 2019 998,000.00
API Access

PolyPid Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PYPD&period=max&api_key=YOUR_API_KEY